Floatz logo

Tolterodine

Chronic Pain

Insel Gruppe AG, University Hospital BernSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
73/ 100

Competitive context

101 Active assets in the Chronic Pain cohort.

Asset / SponsorPhaseRating
(±)-TRAMADOL
EMS
Phase 4BBB
LIDOCAINE
National and Kapodistrian University of Athens
Phase 4BBB
METHADONE
Cari Health Inc.
Phase 4BBB
NEPENTHE
Bursa City Hospital
Phase 4BBB
FENTANYL
Aga Khan University
Phase 4BBB

View all 50 →

Same molecule, other indications

Tolterodine is also rated in:

Low Back PainDormant
B
Indicative ·
62 / 100
View asset →
neuralgiaDormant
CC
Indicative ·
46 / 100
View asset →
chronic prostatitisDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →